Riders don’t care what kind of system you use. They care that it works and provides what they expect. They expect real-time updates, simple account management, and zero surprises. And public transit ...
The need to quickly administer naloxone to counter opioid overdoses has spurred innovation in drug delivery for years, with intramuscular, subcutaneous and nasal doses all used, but the approaches all ...
The long-term goal of a fully automated insulin delivery (AID) system that operates without user input to maintain glucose levels within target range remains a future aspiration and may never be fully ...
The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results